Next Article in Journal
Identification of Electronic and Structural Descriptors of Adenosine Analogues Related to Inhibition of Leishmanial Glyceraldehyde-3-Phosphate Dehydrogenase
Next Article in Special Issue
Chelator-Accelerated One-Pot ‘Click’ Labeling of Small Molecule Tracers with 2-[18F]Fluoroethyl Azide
Previous Article in Journal
Spectroscopic Studies of Amino Acid Ionic Liquid-Supported Schiff Bases
Article Menu

Export Article

Open AccessReview
Molecules 2013, 18(5), 5005-5031;

Folate-Based Radiotracers for PET Imaging—Update and Perspectives

Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen-PSI 5232, Switzerland
Received: 25 March 2013 / Revised: 13 April 2013 / Accepted: 19 April 2013 / Published: 29 April 2013
(This article belongs to the Special Issue PET Chemistry in Molecular Imaging)
Full-Text   |   PDF [521 KB, uploaded 18 June 2014]   |  


The folate receptor (FR) is expressed in many tumor types, among those ovarian and lung cancer. Due to the high FR affinity of folic acid, it has been used for targeting of FR-positive tumors, allowing specific delivery of attached probes to the malignant tissue. Therefore, nuclear imaging of FR-positive cancer is of clinical interest for selecting patients who could benefit from innovative therapy concepts based on FR-targeting. Positron emission computed tomography (PET) has become an established technique in clinical routine because it provides an increased spatial resolution and higher sensitivity compared to single photon emission computed tomography (SPECT). Therefore, it is of critical importance to develop folate radiotracers suitable for PET imaging. This review article updates on the design, preparation and pre-clinical investigation of folate derivatives for radiolabeling with radioisotopes for PET. Among those the most relevant radionuclides so far are fluorine-18 (t1/2: 110 min, Eavβ+: 250 keV) and gallium-68 (t1/2: 68 min, Eav β+: 830 keV). Recent results obtained with new PET isotopes such as terbium-152 (t1/2: 17.5 h, Eβ+: 470 keV) or scandium-44 (t1/2: 3.97 h, Eav β+: 632 keV) are also presented and discussed. Current endeavors for clinical implementation of PET agents open new perspectives for identification of FR-positive malignancies in patients. View Full-Text
Keywords: folate receptor; folic acid; PET; 68Ga, 18F, 152Tb, 44Sc; cancer, imaging folate receptor; folic acid; PET; 68Ga, 18F, 152Tb, 44Sc; cancer, imaging

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Müller, C. Folate-Based Radiotracers for PET Imaging—Update and Perspectives. Molecules 2013, 18, 5005-5031.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top